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SUMMARY 
 
Mycobacterium tuberculosis has a cell envelope incorporating a peptidoglycan-linked 
arabinogalactan esterified by long-chain mycolic acids. A range of “free” lipids are 
associated with the “bound” mycolic acids, producing an effective envelope outer 
membrane. The distribution of these lipids is discontinuous among mycobacteria and 
such lipids have proven potential for biomarker use in tracing the evolution of 
tuberculosis. A plausible evolutionary scenario involves progression from an 
environmental organism, such as Mycobacterium kansasii, through intermediate 
“smooth” tubercle bacilli, labelled “Mycobacterium canettii”; cell envelope lipid 
composition possibly correlates with such a progression. M. kansasii and “M. 
canettii” have characteristic lipooligosaccharides, associated with motility and 
biofilms, and glycosyl phenolphthiocerol dimycocerosates (“phenolic glycolipids”). 
Both these lipid classes are absent in modern M. tuberculosis sensu stricto, though 
simplified phenolic glycolipids remain in certain current biotypes. Dimycocerosates 
of the phthiocerol family are restricted to smaller phthiodiolone diesters in M. 
kansasii. Diacyl and pentaacyl trehaloses are present in “M. canettii” and M. 
tuberculosis, where they are accompanied by related sulfated acyl trehaloses. In 
comparison with environmental mycobacteria, subtle modifications in mycolic acid 
structures in “M. canettii” and M. tuberculosis are notable. The probability of 
essential tuberculosis evolution taking place in Pleistocene megafauna, rather than 
Homo sapiens, is reemphasised. 
 
 
 
Keywords: Tuberculosis; Evolution; Lipids; Biomarkers; Zoonosis 
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1. Introduction 
 
Tuberculosis is an ancient disease, whose pre-Holocene history is shrouded in 
mystery. Analysis of skeletal material has provided evidence for tuberculosis in Homo 
sapiens at up to 9,000 years (9 ka) before present (BP),1 almost back to the start of the 
Holocene. Travelling back from the Holocene into the cyclical glacial times of the 
Pleistocene, human skeletal material becomes scarce and no direct evidence for any 
tuberculosis in H. sapiens has been demonstrated. In contrast, distinctive tuberculosis 
lesions have been recorded in a range of megafauna and other animals from that 
epoch. Typically, the lesions take the form of undermined articular surfaces, as 
exemplified by a metacarpal from Bison antiquus recovered from Natural Trap Cave, 
Wyoming.2 In addition to the bison metacarpal, 19% of 1,002 125 ka to 8 ka BP bovid 
specimens3 and 52% of 113 38 ka to 10 ka BP mastodon bones4 had similar lesions 
indicative of tuberculosis. Bone lesions cannot be considered as complete proof of 
tuberculosis diagnosis, but the dearth of comparable lesions in bones from H. sapiens, 
over the same time period, is very striking. To resolve this conundrum it has been 
proposed2 that Mycobacterium tuberculosis may have been principally an animal 
disease during its early evolution, with transmission to humans occurring later. 
The use of amplified DNA sequences to diagnose tuberculosis in 
archaeological material has been developed during the past two decades.5 Major 
advances in determining full genomic data have been recently provided by the 
application of so-called “Next Generation Sequencing”6 and the more direct 
“Metagenomic” approach.7 Informative genomic data have been obtained for 
specimens stretching back to 9 ka in H. sapiens1 and 17 ka in extinct Bison antiquus2 
and these diagnoses have been supported by the use of robust lipid biomarkers.1,2,5 
The most diagnostic lipids have been mycolic, mycocerosic and mycolipenic acids 
and members of the phthiocerol family.1,2,5 These, and a range of other lipids, are vital 
components in the integrity of the cell envelopes of the tubercle bacillus and related 
taxa.8 Their distribution, however, is discontinuous and changes in lipid composition 
and structure may well be important factors in the evolution of effective pathogenic 
species. The aim of this paper is to outline a rational scenario for the evolution of the 
current M. tuberculosis complex from possible environmental candidates. The 
speculative focus will be on correlating changes in cell envelope lipid composition 
with developing pathogenicity, taking into account the suitability of particular animal 
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hosts along the way. Representative structures of the key lipids under consideration 
are shown in Figures 1 and 2. 
 
2. An environmental opportunist to a perfect pathogen? 
 
The challenge is to chart a pathway from ancestral environmental freely-
circulating mycobacterial species to M. tuberculosis sensu stricto, an obligate 
pathogen with no environmental niche. Currently favoured hypotheses all point to an 
evolutionary bottle-neck, initiated around 35 ka BP.9,10 Subsequent to this time period, 
the evolution of a range of particular clades follows an almost linear clonar 
evolutionary pattern, with key deletions leading to the well-defined modern M. 
tuberculosis complex (MTBC) causing tuberculosis in humans and various animals.11-
13
 
There is increasing evidence that, before reaching the discontinuity of the 
bottle-neck, extensive horizontal gene transfer (HGT) was taking place in ancestral 
tuberculosis strains.10,14 These strains may not necessarily have been obligate 
pathogens but opportunist mycobacteria with the ability to survive in the hostile 
environment of an animal stomach. The rich flora of multiple animal stomachs would 
provide plentiful opportunities for HGTs, eventually resulting in interim organisms 
with an enhanced potential to cause tuberculosis. Prime candidates for such a role are 
pre-bottle-neck ancestral strains, sometimes termed “M. prototuberculosis”,9 which 
are associated with the “smooth” colony-forming “Canetti” variants of M. 
tuberculosis.15,16 “Mycobacterium canettii” smooth strains continue to be encountered 
in isolated cases of tuberculosis, but they are usually confined to certain locations in 
the Horn of Africa.15  
A case for M. marinum as the pivotal environmental source organism has been 
advanced,17 but several key factors mitigate against such a selection. The 
stereochemistries of the M. marinum PDIM waxes and PGLs are completely different 
from those produced by M. tuberculosis and M. kansasii.8,18 In addition, the 
oxygenated mycolic acids of M. marinum are not cyclopropanated, in contrast with 
those from M. tuberculosis and M. kansasii.18,19 The environmental organism that 
phenotypically resembles M. tuberculosis most closely is Mycobacterium kansasii and 
this relationship has been supported by genomic comparisons.20,21 Cogent arguments 
have been advanced to associate the evolution of tubercle bacilli with bacteria similar 
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to M. kansasii, including indications of HGTs between these taxa.20,21 Key genes 
acquired by HGT include those coding for mycobacterial lipids, transferases and 
proteins related to adaptation to anaerobic conditions.20,21 M. kansasii still causes 
pulmonary disease in Silesian and South African miners, the bacterium being 
contracted from water in showers.21 In developing a coherent evolutionary route, the 
pathway from M. kansasii, through “M. canettii”, to M. tuberculosis is a good 
working hypothesis. Changes in lipid composition are potentially very significant, 
involving the mycolic acids, phthiocerol dimycocerosates (PDIMs), glycosyl 
phenolphthiocerol dimycocerosates (“phenolic glycolipids”, PGLs) (Figure 1), diacyl 
trehaloses (DATs), pentaacyl trehaloses (PATs) and sulfated acyl trehalose 
glycolipids (SGLs) (Figure 2).8  
 
3. Does lipid evolution parallel M. tuberculosis evolution? 
 
3.1 Mycolic acids 
 
Possibly the most deep-lying fundamental differences between the lipids from 
M. kansasii and members of the M. tuberculosis complex (MTBC), loosely including 
“M. canettii”, are subtle changes in mycolic acid structure.  Mycolates from MTBC 
have characteristic 24-carbon chains in 2-position, whereas the mycolates from M. 
kansasii and the majority of mycobacteria have principally 22-carbon side chains.8,19 
In addition, the MTBC α-mycolates show a significant shortening of the size of the 
chain between carbon-3 and the proximal cyclopropane (17 → 13 carbons) and the 
lengthening of the terminal chain (18 → 20 carbons) beyond the distal cyclopropane 
unit, as compared with M. kansasii (Figure 1A).19 The methoxymycolates and 
ketomycolates of “M. canettii” and M. tuberculosis (Figure 1A) conform to the 
general pattern of these components in related mycobacteria, such as M. kansasii, but, 
significantly, these oxygenated mycolates are slightly larger than any others.19 
The balance of the three main types of mycolates is possibly significant; the 
ratios of the α-, methoxy- and ketomycolates are, respectively, ~10:5:8 for M. 
kansasii, ~10:6:8 for “M. canettii” and ~10:5:5 for M. tuberculosis.19 Having half of 
the proportions as α-mycolates in M. tuberculosis may be quite significant. The major 
all cis-cyclopropyl α-mycolates of all three taxa are similar in size, centred around 80 
carbons. Those from M. kansasii are restricted to 80 and 82 carbons overall, but there 
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are four detailed structural varieties of each giving a heterogeneous mixture of eight 
distinct α-mycolates.19 In contrast, the four α-mycolates from “M. canettii” and M. 
tuberculosis are all very uniform, the two major C78 and C80 components being 
accompanied by minor C82 and C84 mycolates.19 It is particularly notable that the 
central (14-carbon) and distal (20-carbon) meromycolate chains are invariable in the 
α-mycolates from “M. canettii” and M. tuberculosis (Figure 1A).19 The complex 
methoxymycolates from M. kansasii, totalling eight cis- and four trans-components, 
have a cis:trans ratio of ~3:2,whereas both “M. canettii” and M. tuberculosis have an 
enhanced cis:trans ratio of ~3:1.19 Somewhat simplified methoxymycolates, with six 
cis- and two trans-components are found in “M. canettii”, simplifying further to 
mainly a C85 and lesser C87 cis- and a single trans-methoxymycolate in M. 
tuberculosis.19 The trans-ketomycolates predominate over the cis-forms in M. 
kansasii (~6:1), “M. canettii” (~4:1) and M. tuberculosis (~3:2, respectively); the 
latter two have mainly a C87 trans-ketomycolate accompanied by six very minor 
variants but this contrasts with a heterogeneous mix of ten in M. kansasii.19  
The essence of the above seemingly complex changes is an apparent 
simplification and tightening up of mycolate composition. Mycolic acids are 
“cornerstones” of the mycobacterial outer membrane, providing a covalent 
hydrophobic inner leaflet, facilitating binding of the range of “free lipids” (Figures 1 
and 2) that comprise the outer leaflet.8 Physical studies indicate that ketomycolates 
appear to have a prime structural role in adopting tightly folded conformations to 
produce a solid foundation.22 It is not surprising, therefore, that there is minimal 
variation in the general structure of ketomycolates between, for example, M. kansasii 
and MTBC (Figure 1A). In contrast, the structurally different α-mycolates from M. 
kansasii and MTBC (Figure 1A) behave quite distinctly in monolayer studies.22 As 
noted above α-mycolates constitute half of the overall mycolates in M. tuberculosis, 
reinforcing the possibility of important modifications in cell envelope interactions 
with a special range of free lipids (Figures 1 and 2). 
 
3.2 Dimycocerosates of the phthiocerol family and glycosyl phenolphthiocerols 
 
The phthiocerol dimycocerosate (PDIM) waxes are important tuberculosis 
virulence factors and the “M. canettii” and M. tuberculosis examples are the largest 
(Figure 1B).8,23 The M. tuberculosis complex phthiocerol family has major C34/C36 
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phthiocerol A components, minor C33/C35 phthiocerol Bs and C33/C35 phthiodiolones 
(Figure 1B).2,8,23 In contrast, M. kansasii PDIM waxes were much smaller, having 
only C25/C27 phthiodiolones (Figure 1B) and no methoxylated phthiocerol As and 
Bs.23 Interestingly, the mainly C29/C30/C32 mycocerosic acid composition of M. 
kansasii PDIM waxes is comparable with that of the M. tuberculosis complex.23 
The glycosyl phenolphthiocerol dimycocerosates, the so-called “phenolic 
glycolipids” (PGLs) (Figure 1C), are related to the PDIMs (Figure 1B).8,23 The PGLs 
from “M. canettii” comprise a 2-O-methyl rhamnosyl PGL and an extended 
triglycosyl PGL; interestingly, the main PGL produced by M. kansasii is extended 
further by an additional sugar (Figure 1C).8,23 This close structural similarity in PGLs 
has been highlighted in schemes suggesting an evolutionary progression from M. 
kansasii to “M. canettii”.21 The PGLs from M. kansasii do include a methoxylated 
phenolphthiocerol component (Figure 1C), in contrast to the situation for the PDIM 
waxes (Figure 1B).23 The 2-O-methyl rhamnosyl PGL is also characteristic of modern 
ecotypes, such as M. bovis, M. africanum and some so-called “Beijing” lineages of M. 
tuberculosis24 (Figure 1C). However, PGLs are not present in a large clade of modern 
TB lineages due to a decisive pks 15/1 gene frameshift.25  
 
3.3 Glycolipids based on trehalose 
 
In addition to PGLs, M. kansasii and “M. canettii” are characterised by the 
production of a range of highly polar antigenic lipooligosaccharides (LOSs) (Figure 
2A, B).26 The main M. kansasii LOS (Figure 2A) has an acylated thirteen sugar 
oligosaccharide, based on trehalose, but that from “M. canettii” is refined down to an 
unrelated acyl trehalose nonasaccharide (Figure 2B). It has been clearly demonstrated, 
for M. marinum and M. kansasii, that these relatively hydrophilic LOSs promote 
biofilm formation and motility.27 These characteristics may have a useful survival role 
for free-living organisms and HGTs may be facilitated by such behaviour. However, 
once an opportunist Mycobacterium had evolved into an obligate parasite, the 
production of LOSs may no longer have conveyed a competitive advantage. Indeed, it 
has been shown that smooth variants of M. kansasii, containing LOSs, are rapidly 
cleared from the organs of infected animals, but rough variants, lacking all LOSs, 
produce chronic systemic infections.28 It is possible to surmise that the loss of LOSs is 
a key event in the transition from a free-living opportunist Mycobacterium to a 
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transmissible obligate pathogen. This may be as significant a change as the pks 15/1 
gene frameshift that resulted in the loss of PGLs.25 
The diacyl trehaloses (DATs) and pentaacyl trehaloses (PATs) are two 
glycolipid classes also based on a trehalose scaffold (Figure 2C).8,18 First 
characterised from M. tuberculosis H37Rv, DATs and PATs are present in 
representative modern clinical strains, as well as in “M. canettii”,8,18 but they have not 
been characterised from M. kansasii. The multimethyl-branched fatty acid 
components of DATs are C24 2,4-dimethyl docosanoic (“mycosanoic”) (Figure 2Ca) 
and C27 3-hydroxy 2,4,6-trimethyl tetracosanoic (“mycolipanolic”) (Figure 2Ca’).8 
The related characteristic main fatty acid in PATs is C27 2,4,6-trimethyl tetracos-2-
enoic (“mycolipenic”) acid (Figure 2Cb).8,18 It is very significant that the absolute 
stereochemistry of the methyl-branched centres in all these acids (Figure 2C) is S in 
contrast to the R configuration in the mycocerosates (Figure 1C). The related sulfated 
acyl trehalose glycolipids (SGLs) also feature multimethyl-branched fatty acid 
components of the S series, examples being the C37 phthioceranic acids and C40 
hydroxyphthioceranic (Figure 2Cc,d).8 Sulfoglycolipids (SGLs) are restricted to 
modern M. tuberculosis and they have not been found in “M. canettii”.29 
 
3.4 Overall summary of lipid correlations 
 
In summary, it is clear that in charting a hypothetical progression from M. 
kansasii, via “M. canettii”, to M. tuberculosis there are identifiable changes in cell 
envelope lipid composition. The challenge is to pinpoint significant modifications that 
may have contributed to the undoubted success of the biotypes of modern tubercle 
bacilli. Scrutiny of the complex profiles of the α-, methoxy- and ketomycolates 
indicates a tightening up both in structural details and distribution of types, but the 
most significant change is undoubtedly the presence of a longer 2-alkyl chain and 
very specific alterations in the proximal and α-mycolate distal chain lengths (Figure 
1A) for “M. canettii” and M. tuberculosis. It is enticing to speculate that the distinct 
α-mycolate (Figure 1A) may be influential in the outer membrane, enhancing links 
with the particular portfolios of free lipids (Figures 1 and 2) found in “M. canettii” 
and M. tuberculosis. The exceptionally long members of the whole phthiocerol family 
(Figure 1B), from the PDIMs of “M. canettii” and M. tuberculosis, also distinguish 
these taxa; in contrast, M. kansasii only has much smaller phthiodiolones (Figure 1B).  
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The apparent structural change in PGLs from M. kansasii to “M. canettii” has 
been advanced previously as evidence of a close evolutionary linking of these taxa.21 
The principal M. kansasii PGL is truncated by both one and three sugars to produce 
comparable proportions of triglycosyl and monoglycosyl PGLs in “M. canettii”. 
Modern post-bottleneck MTBC biotypes fall into two distinct categories, with respect 
to PGL production; monoglycosyl PGLs are retained in M. africanum, M. bovis and 
the M. tuberculosis “Beijing” and related clades, but a major group of modern M. 
tuberculosis lineages have lost the ability to produce PGLs.25 M. kansasii and “M. 
canettii” both produce a range of highly polar LOSs,26 associated with aquatic 
environments, motility and biofilms; modern MTBC organisms lack these lipids. 
LOSs are based on acylated trehaloses (Figure 2A, B) and several other classes of 
trehalose-based glycolipids are encountered (Figure 2C). The polar antigenic DATs 
and apolar PATs are characteristic of “M. canettii” and M. tuberculosis sensu strictu, 
but the closely-related, relatively polar, SGLs are limited to the latter category. A 
most significant feature of DATs, PATs and SGLs is the presence of multimethyl-
branched fatty acids of the S series (Figure 2C), rather than the R methyl branches in 
the mycocerosates from the PDIMs and PGLs (Figure 1B, C). It would be interesting 
to determine if the genomic origin of these longer S series multimethyl-branched fatty 
acids, from DATs, PATs and SGLs (Figure 2C), correlates with the shorter S series 
fatty acids found in LOSs (Figure 2A). In view of the fact that the multimethyl-
branched fatty acid components of the PDIMs and PGLs from M. marinum are also of 
the S series,8,18,23 the possibility of HGT from this source should be considered. 
A hypothesis is being advanced, here, for an outline model evolutionary 
pathway for modern tubercle bacilli from an environmental organism, such as M. 
kansasii, via the very diverse group of “smooth” isolates provisionally gathered 
together under the label “M. canettii”. Perceived significant lipid changes, in the taxa 
under consideration, are summarised in Figure 3, but such stylised changes would 
necessarily be much less compartmentalised than indicated. The tremendous diversity 
of extant smooth “M. canettii” strains16 indicates that a complex labyrinth of 
pathways may have been followed to evolve these taxa. Indeed, extant “M. canettii” 
are not necessarily good representatives of the first mycobacteria that developed a 
preference for mammalian antibiosis/symbiosis rather than free-living; however they 
are the best existing signposts. As noted earlier, bovid metacarpal lesions point to the 
presence of tuberculosis back to 125 ka BP,3 so productive mammalianisation and 
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adaptation of an environmental candidate could have taken place over a period of up 
to 100 ka at least. Modern tuberculosis was distilled out of such a melange, but again 
there may be no single definitive pathway. However, tuberculosis evolution was 
brought into sharper focus during passage through the clear bottleneck,9,10,13 which 
preceded the relatively rapid evolution of all the modern biotypes.9-13 The dearth of 
human skeletal material makes it difficult to delineate the true role of H. sapiens in 
accelerating tuberculosis evolution. Suffice it to say, however, that when settled 
human communities were established, modern tuberculosis found a convenient niche 
from which to expand and diversify. 
 
4. Where on earth did tubercle bacilli evolve and who were the host vectors?  
 
To return to the hypothesis of a possible key zoonotic origin of the M. 
tuberculosis complex, an environmental mycobacterial common ancestor might well 
have prospered in primeval waters. Aqueous suspensions of these bacteria could then 
have been repeatedly passaged through a range of prehistoric animals, such as bovids 
and mastodons.3,4 The possible involvement of protozoa as a direct vector into 
humans has been suggested,14 but such microorganisms could also be incidental 
surrogates facilitating transmission into animals and not specific direct vectors. It has 
been indicated20,21 that tubercle bacilli have probably adopted genes favouring 
survival in anaerobic conditions, thereby encouraging growth in the reduced oxygen 
environment of animal cells. It has been argued that Pleistocene bovids and 
mastodons may have lived in almost symbiosis with ancestral tubercle bacilli for 
many aeons,3,4 perhaps allowing the slow accumulation of variants that caused the 
widespread lesions indicative of tuberculosis. However, the cyclical changes during 
the Ice Ages may have eventually produced an unfavourable environment in which 
the presence of an infecting agent may have contributed significantly to the demise of 
these characteristic animal species. 
The proposed scheme is not in general accord with a recent detailed 
examination of the parallel evolution of genomes from 186 members of the M. 
tuberculosis complex and 4,995 human mitochondria.30 Extrapolation of the results 
were interpreted to suggest that TB and humans co-evolved “out of Africa”, 
commencing ~70 ka ago.30 However, parallel evolution is not necessarily linked co-
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evolution and no definitive evidence was advanced to substantiate the presence of any 
human tuberculosis going back as far as 70 ka BP.  
The scenario, outlined in this communication, is just one of many zoonotic 
possibilities, but the general outcome could be an obligate animal pathogen causing a 
disease that is now recognised as tuberculosis. On the balance of evidence, a major 
ancient reservoir of this global disease would appear to be a range of prehistoric large 
animals, spread throughout the Northern Hemisphere.3,4 The transmission to humans 
could well have been through ingestion of infected animal material, analogous to the 
way that modern bovine tuberculosis can be contracted by drinking raw milk or eating 
undercooked infected meat. The eventual gathering together of human communities 
could have facilitated a transition to the inter-person spread of modern human 
tuberculosis.  
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Figure legends 
 
Figure 1. Representative structures of mycolic acids and phthiocerol and 
phenolphthiocerol-based lipids. (A) Mycolic acids, showing chain length differences 
between M. kansasii α-mycolates and those from “M. canettii” and M. tuberculosis. 
The main methoxy- and ketomycolates from M. tuberculosis are shown; those from 
M. kansasii are essentially similar. (B) Dimycocerosates of the main M. kansasii 
phthiodiolone and M. tuberculosis and “M. canettii” phthiocerol As. (C) Phenolic 
glycolipids (PGLs) from M. kansasii, “M. canettii” and M. bovis. 
 
Figure 2. Representative structures of trehalose-based glycolipids. (A) The main 
lipooligosaccharide (LOS) from M. kansasii. (B) The main lipooligosaccharide (LOS) 
from “M. canettii”. (C) The main diacyl (DAT), pentaacyl (PAT) and sulfated acyl 
(SGL) trehalose glycolipids. The DAT with C24-mycosanoate, a), is accompanied by a 
DAT with C27-mycolipanolate, a’).  
 
Figure 3. Correlation of lipid composition of M. kansasii, “M. canettii” and M. 
tuberculosis in the context of hypothetical linked evolution. Cartoon structures aim to 
reflect the clear differences in the α-mycolates of M. kansasii, in comparison with 
those of “M. canettii” and M. tuberculosis; shown in detail in Figure 1A. The 
numbers of sugars in particular LOSs and PGLs are shown in brackets with an 
asterisk, e.g. LOS (13)*. 
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